Healthcare Pros Back Medical Cannabis Despite Training Gap: Survey
89% of 879 surveyed healthcare professionals see medical cannabis utility, but most lack formal training on clinical integration, highlighting sector growth potential.
Healthcare professionals overwhelmingly recognize medical cannabis as clinically valuable, with 89% of surveyed practitioners acknowledging therapeutic benefits according to new research published in the Journal of Cannabis Research. The anonymous survey of 879 healthcare workers reveals a striking disconnect between professional acceptance and formal education, as most respondents report encountering patient cannabis use without adequate training on clinical integration.
The survey data underscores expanding mainstream medical acceptance that continues driving cannabis sector fundamentals. As healthcare professionals increasingly view cannabis as legitimate medicine rather than recreational substance, patient access programs gain institutional support that translates into sustained market demand. This professional endorsement provides regulatory cover for state expansion programs and federal rescheduling efforts.
The training gap identified in the survey represents both challenge and opportunity for cannabis companies focused on medical markets. Healthcare professionals want guidance on dosing, drug interactions, and patient selection criteria - creating demand for educational services and standardized products. Companies like Curaleaf (CURLF) and Green Thumb Industries (GTBIF) already invest heavily in medical practitioner outreach programs to capture this professional interest.
Patient-driven adoption continues outpacing formal medical integration, with survey respondents noting they encounter cannabis use regardless of their prescribing comfort level. This bottom-up demand pattern has historically preceded broader medical acceptance and suggests continued market expansion even without comprehensive federal reform. Healthcare professional endorsement legitimizes patient choices and reduces stigma barriers that have constrained market growth.
The survey findings support bullish projections for medical cannabis markets, particularly in states with robust patient access programs. As healthcare professionals gain confidence through training and experience, prescription-like recommendations will likely increase, driving higher per-patient spending and more consistent usage patterns compared to adult-use markets. This professional validation cycle has proven crucial for cannabis companies seeking sustainable revenue growth beyond recreational sales volatility.